Antithrombotic therapy in children

Chest

Volumn 108, Issue 4 SUPPL., 1995, Pages 506S-522S

  Michelson, A D ^a   Bovill, E ^a   Andrew, M ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; AMOXICILLIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CARBAMAZEPINE; CEFACLOR; CLOXACILLIN; COTRIMOXAZOLE; HEPARIN; PHENOBARBITAL; PHENYTOIN; PREDNISONE; RANITIDINE; STREPTOKINASE; UROKINASE;

BLEEDING; CHILD; CHILD CARE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE CALCULATION; DRUG MECHANISM; HEART VALVE PROSTHESIS; HEPARINIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

EID: 0028876999     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.108.4_Supplement.506S     Document Type: Conference Paper

References (205)

1. Andrew M Marzinotto V Brooker L Oral anticoagulant therapy in pediatric patients: a prospective study Thromb Haemost 71 1994 265 269
2. Massicotte P, Marzinotto V, Vegh P, et al. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor. J Pediatr (in press)
3. Andrew M Paes B Milner R Development of the human coagulation system in the full-term infant Blood 70 1987 165 172
4. Andrew M Paes B Johnston M. Development of the hemostatic system in the neonate and young infant Am J Pediatr Hematol Oncol 12 1990 95 104
5. Andrew M Paes B Milner R Development of the human coagulation system in the healthy premature infant Blood 72 1988 1651 1657
6. Hirsh J Dalen J Warkentin T Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety Chest 108 1995 258S 275S
7. Schmidt B Ofosu FA Mitchell L Anticoagulant effects of heparin in neonatal plasma Pediatr Res 25 1989 405 408
8. Andrew M Schmidt B Mitchell L Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin Thromb Haemost 63 1990 27 30
9. Andrew M Mitchell L Vegh P Thrombin regulation in children differs from adults in the absence and presence of heparin Thromb Haemost 72 1994 836 842
10. Hirsh J. Heparin N Engl J Med 324 1991 1565 1574
11. Andrew M Marzinotto V Blanchette V Heparin therapy in pediatric patients: a prospective cohort study Pediatr Res 35 1994 78 83
12. Raschke RA Reilly BM Guidry JR The weight-based heparin dosing nomogram compared with a “standard care” nomogram Ann Intern Med 119 1993 874 881
13. Gallus A Jackaman J Tillett J Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism Lancet 2 1986 1293 1296
14. Hull RD Raskob GE Rosenbloom D. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis N Engl J Med 322 1990 1260 1264
15. Holmgren K Andersson G Fagrell B One-month versus 6-month therapy with oral anticoagulants after symptomatic deep vein thrombosis Acta Med Scand 218 1985 279 284
16. Andrew M Ofosu FA Schmidt B Heparin clearance and ex vivo recovery in newborn piglets and adult pigs Thromb Res 52 1988 517 527
17. McDonald MM Jacobson LJ Hay WW Heparin clearance in the newborn Pediatr Res 15 1981 1015 1018
18. Turner Gomes S Nitschmann E Benson L Heparin is cleared faster in children with congenital heart disease than adults [abstract] J Am Coll Cardiol 21 1993 59 a
19. Hirsh J van Aken WG Gallus AS Heparin kinetics in venous thrombosis and pulmonary embolism Circulation 53 1976 691 695
20. Chiu HM van Aken WG Hirsh J Increased heparin clearance in experimental pulmonary embolism J Lab Clin Med 90 1977 204 215
21. Cruickshank MK Levine MN Hirsh J A standard heparin nomogram for the management of heparin therapy Arch Intern Med 151 1991 333 337
22. Elliot GC Hiltunen SJ Suchyta M Physician-guided treatment compared with a heparin protocol for deep vein thrombosis Arch Intern Med 154 1994 999 1004
23. Murdoch LA Beattie RM Silver DM. Heparin-induced thrombocytopenia in children Acta Paediatr 82 1993 495 497
24. Spadone D Clark F James E Heparin-induced thrombocytopenia in the newborn J Vasc Surg 15 1992 306 311
25. Mocan H Beattie TJ Murphy AV. Renal venous thrombosis in infancy: long-term follow-up Pediatr Nephrol 5 1991 45 49
26. Hathaway W Corrigan J. Report of scientific and standardization subcommittee on neonatal hemostasis Thromb Haemost 65 1991 323 325
27. Corrigan JJ. Normal hemostasis in fetus and newborn: coagulation Polin RA Fox WW Fetal and neonatal physiology 1992 WB Saunders Philadelphia 1368 1371
28. Hathaway WE Bonnar J. Hemostatic disorders of the pregnant woman and newborn infant 1987 Elsevier Science Publishing New York 65 82
29. Bovill EG Soll RF Lynch M Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate Blood 81 1993 77 83
30. Andrew M Vegh P Johnston M Maturation of the hemostatic system during childhood Blood 80 1992 1998 2005
31. Massicotte MP Marzinotto V Adams M Coumarin suppresses thrombin regulation to a greater extent in children compared to adults [abstract] Thromb Haemost 73 1995 1117
32. Schmidt B Andrew M. Report of scientific and standardization subcommittee on neonatal hemostasis diagnosis and treatment of neonatal thrombosis Thromb Haemost 67 1992 381 382
33. Andrew M Marzinotto V Pencharz P A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home J Pediatr 126 1995 358 363
34. Carpentieri U Nghiem QX Harris LC. Clinical experience with an oral anticoagulant in children Arch Dis Child 51 1976 445 448
35. Woods A Vargas J Berri G Antithrombotic therapy in children and adolescents Thromb Res 42 1986 289 301
36. Doyle JJ Koren G Chen MY Anticoagulation with sodium warfarin in children: effect of a loading regimen J Pediatr 113 1988 1095 1097
37. Evans DIK Rowlands M Poller L. Survey of oral anticoagulant treatment in children J Clin Pathol 45 1992 707 708
38. Hathaway WE. Use of antiplatelet agents in pediatric hypercoagulable states AJDC 138 1984 301 304
39. Bradley LM Midgley FM Watson DC Anticoagulation therapy in children with mechanical prosthetic cardiac valves Am J Cardiol 56 1985 533 535
40. Hirsh J. Oral anticoagulant drugs: review article N Engl J Med 324 1991 1865 1875
41. Andrew M David M Adams M Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE Blood 83 1994 1251 1257
42. Aballi AJ de Lamerens S. Coagulation changes in the neonatal period and in early infancy Pediatr Clin North Am 9 1962 785 817
43. 1 in mothers and their newborn babies Lancet 2 1982 460 463
44. 2 (menaquinone) status in newborns during the first week of life Pediatrics 81 1988 137 140
45. 1) in human milk, cow's milk and infant formula foods determined by high-performance liquid chromatography J Nutr 112 1982 1105 1117
46. 1 supplements given to the mother Pediatr Res 22 1987 513 517
47. Andrew M. The hemostatic system in the infant Nathan D Oski F Hematology of infancy and childhood 1992 WB Saunders Philadelphia 115 154
48. Lehman ME Kolb KW Barnhart GR Warfarin absorption in a patient with short-bowel syndrome Clin Pharm 4 1985 325 326
49. Von Kries R Stannigel H Gobel U. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation Eur J Pediatr 114 1985 191 194
50. Kumar S Haigh JRM Rhodes LE Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy Thromb Haemost 62 1989 729 732
51. Stewart S Cianciotta D Alexson C The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valves J Thorac Cardiovasc Surg 93 1987 551 554
52. El Makhlouf A Friedli B Oberhansli I Prosthetic heart valve replacement in children J Thorac Cardiovasc Surg 93 1987 80 85
53. Sade RM Crawford FA Jr Fyfe DA Valve prostheses in children: a reassessment of anticoagulation J Thorac Cardiovasc Surg 95 1988 553 561
54. Rao S Solymar L Mardini MK Anticoagulant therapy in children with prosthetic valves Ann Thorac Surg 47 1989 589 592
55. Serra AJS McNicholas KW Olivier HF Jr The choice of anticoagulation in pediatric patients with the St. Jude Medical valve prostheses J Cardiovasc Surg 28 1987 588 591
56. McGrath LB Gonzalez-Lavin L Eldredge WJ Thromboembolic and other events following valve replacement in a pediatric population treated with antiplatelet agents Ann Thorac Surg 43 1987 285 287
57. Spevak PJ Freed MD Castaneda AR Valve replacement in children less than 5 years of age J Am Cardiol 8 1986 901 908
58. Harada Y Imai Y Kurosawa H Ten-year follow-up after valve replacement with the St. Jude medical prosthesis in children J Thorac Cardiovasc Surg 100 1990 175 180
59. Hooshang T Capitanio MA. Tracheobronchial calcification: an observation in three children after mitral valve replacement and warfarin sodium therapy Radiology 176 1990 728 730
60. Piro LD Whyte MP Murphy WA Normal cortical bone mass in patients after long term Coumadin therapy J Clin Endocrinol Metab 54 1982 470 473
61. Rosen HN Maitland LA Suttie JW Vitamin K and maintenance of skeletal integrity in adults Am J Med 94 1993 62 68
62. Rajasekhar D Kestin AS Bednarek FJ Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood Thromb Haemost 72 1994 957 963
63. Ts'ao CH Green D Schultz K. Function and ultrastructure of platelets of neonates: enhanced ristocetin aggregation of neonatal platelets Br J Haematol 32 1976 225 233
64. Katz JA Moake JL McPherson PD Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma Blood 73 1989 1851 1858
65. Weinstein MJ Blanchard R Moake JL Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenia purpura Br J Haematol 72 1989 68 72
66. Sanders JM Holtkamp CA Buchanan GR. The bleeding time may be longer in children than in adults Am J Pediatr Hematol Oncol 12 1990 314 318
67. Aversa LA Vasquez A Penalver JA Bleeding time in normal children J Pediatr Hematol Oncol 17 1995 25 28
68. Schaff HV Danielson GK DiDonato RM Late results after Starr-Edwards valve replacement in children J Thorac Cardiovasc Surg 88 1984 583 589
69. El Makhlouf A Friedli B Oberhansli I Prosthetic heart valve replacement in children J Thorac Cardiovasc Surg 93 1987 80 85
70. Solymar L Rao PS Mardini MK Prosthetic valves in children and adolescents Am Heart J 121 1991 557 568
71. Borkon AM Soule L Reitz BA Five year follow-up after valve replacement with the St. Jude medical valve in infants and children Circulation 74 suppl 1 1986 I-110-15
72. LeBlanc JG Sett SS Vince DJ. Antiplatelet therapy in children with left-sided mechanical prostheses Eur J Cardiothorac Surg 7 1993 211 215
73. Newburger JW Takahashi M Burns JC The treatment of Kawasaki syndrome with intravenous gamma globulin N Engl J Med 315 1986 341 347
74. Bandstra ES Montalvo BM Goldberg RN Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants Pediatrics 82 1988 533 542
75. Ment LR Duncan CC Ehrenkranz RA. Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants J Pediatr 107 1985 937 943
76. Ment LR Duncan CC Ehrenkranz RA. Randomized low dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates J Pediatr 112 1988 948 955
77. Ment LR Ehrenkranz RA Duncan CC. Intraventricular hemorrhage of the preterm neonate: prevention studies Semin Perinatol 12 1988 359 372
78. Bada HS Korones SB Kolni HW Partial plasma exchange transfusion improves cerebral hemodynamics in symptomatic neonatal polycytemia Am J Med Sci 291 1986 157 163
79. Porter JDH Robinson PH Glasgow JFT Trends in the incidence of Reye's syndrome and the use of aspirin Arch Dis Child 65 1990 826 829
80. Remington PL, Shabino CL, McGee H, et al. Reye syndrome and juvenile rheumatoid arthritis in Michigan. AJDC 1395;139: 870–72
81. Makela AL Lang H Korpela P. Toxic encephalopathy with hyperammonaemia during high-dose salicylate therapy Acta Neurol Scand 61 1980 146 151
82. Starko KM Ray CG Dominguez LB Reye's syndrome and salicylate use Pediatrics 66 1980 859 864
83. Halpin TJ Holtzhauer FJ Campbell RJ Reye's syndrome and medication use JAMA 248 1982 687 691
84. Young RSK Toretti D Williams RH Reye's syndrome associated with long-term aspirin therapy JAMA 251 1984 754 756
85. Baum J. Aspirin in the treatment of juvenile arthritis Am J Med 74 1983 10 15
86. Corrigan J Sluth JJ Jeter M Newborn's fibrinolytic mechanism: components and plasmin generation Am J Hematol 32 1989 273 278
87. Andrew M Brooker L Paes B Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration Thromb Haemost 68 1992 325 330
88. Leaker M, Brooker L, Ofosu K, et al. Anisoylated streptokinase-plasminogen activator complex offers no advantage over streptokinase for fibrin clot lysis in cord plasma. Biol Neonate (in press)
89. Leaker M Superina R Andrew M. Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric liver transplant patients Thromb Haemost 60 2 1995 144 147
90. Bovill EG Becker R Tracy RP. Monitoring thrombolytic therapy Prog Cardiovasc Dis 34 1992 279 294
91. Wever MLG Liem KD Geven WB Urokinase therapy in neonates with catheter related central venous thrombosis Thromb Haemost 73 1995 180 185
92. Gore JM Sloan M Price TR Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thrombolysis in myocardial infarction study: thrombolysis in myocardial infarction, phase II, pilot and clinical trial Circulation 83 1991 448 459
93. Collins R Scrimgeour A Yusuf S Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery N Engl J Med 318 1988 1162 1173
94. Clagett GP Reisch JS. Prevention of venous thromboembolism in general surgical patients Ann Surg 208 1988 227 240
95. Castaman G Rodeghiero F Dini E. Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemia Haematologica 75 1990 567 569
96. Wise RC Todd JK. Spontaneous, lower-extremity venous thrombosis in children AJDC 126 1973 766 769
97. Bernstein D Coupey S Schonberg SK. Pulmonary embolism in adolescents AJDC 140 1986 667 671
98. Coon WW Willis PW Keller JB. Venous thromboembolism and other venous disease in the Tecumseh Community Health Study Circulation 48 1973 839 846
99. Gjores JE. The incidence of venous thrombosis and its sequelae in certain districts in Sweden Acta Chir Scand 206 suppl 1956 1 10
100. Carter C Gent M. The epidemiology of venous thrombosis Colman RW Hirsh J Marder VJ Hemostasis and thrombosis: basic principles and clinical practice 1982 JB Lippincott Philadelphia 805 819
101. Uden A. Thromboembolic complications following scoliosis surgery in Scandinavia Acta Orthop Scand 50 1979 175 178
102. David M Andrew M. Venous thromboembolism complications in children: a critical review of the literature J Pediatr 123 1993 337 346
103. Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients Thromb Haemost 74 l 1995 415 425
104. Andrew ME Vegh PA Mitchell LG. Thrombin (IIa) regulation in children differs from adults both in the absence and presence of heparin [abstract] Thromb Haemost 69 1993 764
105. Xu L Delorme M Berry L Alpha-2-macroglobulin remains as important as ATIII for thrombin regulation in cord plasma in the presence of endothelial cell surfaces Pediatr Res 37 1995 1 6
106. Delorme M, Xu L, Berry L, et al. Anticoagulant dermatan sulfate proteoglycan in the term human placenta. J Clin Invest (submitted)
107. Andrew M Mitchell L Paes B An anticoagulant dermatan sulphate proteoglycan circulates in the pregnant women and her fetus J Clin Invest 89 1992 321 326
108. Delorme MA Burrows RF Ofosu FA Thrombin regulation in mother and fetus during pregnancy Semin Thromb Haemost 18 1992 81 90
109. Xu L Delorme M Berry L Thrombin generation in newborn and adult plasma in the presence of an endothelial surface [abstract] Thromb Haemost 65 1991 1230
110. Andrew M Berube C Adams M The relationship between non-specific inhibitors in children with systemic lupus erythematosus and thromboembolic complications: a cross-sectional study [abstract] Lupus 3 4 1994 360
111. Montes de Oca MA Babron MC Bletry O Thrombosis in systemic lupus erythematosus: a French collaborative study Arch Dis Child 66 1991 713 717
112. Schmidt B Andrew A. A prospective international registry of neonatal thrombotic diseases. [abstract] Pediatr Res 35 pt 2 1994 170a
113. Green RM Meyer TJ Dunn M Pulmonary embolism in younger adults Chest 101 1992 1507 1511
114. Lindblad B Bergqvist D. Aggressive or conservative treatment in subclavian vein thrombosis Eklof B Gjores JE Thulesius O Controversies in the management of venous disorders 1989 Butterworth London 141 158
115. Rockoff MA Gang DL Vacanti JP. Fatal pulmonary embolism following removal of a central venous catheter J Pediatr Surg 19 1984 307 309
116. Mulvihill SJ Fonkalsrud EW. Complications of superior versus inferior vena cava occlusion in infants receiving central total parenteral nutrition J Pediatr Surg 19 1984 752 757
117. Mollitt DL Golladay ES. Complications of TPN catheter-induced vena caval thrombosis in children less than 1 year of age J Pediatr Surg 18 1983 462 467
118. Le Coultre C, Oberhansli I, Mossaz A, et al. Postoperative chylothorax in children: differences between vascular and traumatic origin. 37th Annual International Congress of the British Association of Paediatric Surgeons, July 25–27, 1990.
119. Tanaka K Takao M Yada I Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery J Cardiothorac Anesth 3 1989 181 188
120. Graham L Jr Gumbiner CH. Right atrial thrombus and superior vena cava syndrome in a child Pediatrics 73 1984 225 228
121. Bertrand M Presant CA Klein L Iatrogenic superior vena cava syndrome: a new entity Cancer 54 1984 376 378
122. Kramer SS Taylor GA Garfinkel DJ Lethal chylothoraces due to superior vena caval thrombosis in infants Am J Radiol 137 1981 559 563
123. Dhande V Kattwinkel J Alford B. Recurrent bilateral pleural effusions secondary to superior vena cava obstruction as a complication of central venous catheterization Pediatrics 72 1983 109 113
124. Duke WW. The relation of blood platelets to hemorrhagic disease: description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion JAMA 55 1910 1185 1192
125. Marsh D Wilkerson SA Cook LN Right atrial thrombus formation screening using two-dimensional echocardiograms in neonates with central venous catheters Pediatrics 81 1988 284 286
126. Warner BW Gorgone P Schilling S Multiple purpose central venous access in infants less than 1,000 grams J Pediatr Surg 22 1987 820 822
127. Dollery CM Sullivan ID Bauraind O Thrombosis and embolism in long-term central venous access for parenteral nutrition Lancet 344 1994 1043 1045
128. Stockwell M Adams M Andrew M Central venous catheters in children with malignant disorders Arch Dis Child 58 1983 633 663
129. Zoller B Svensson PJ He X Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C J Clin Invest 94 1994 2521 2524
130. Auletta MJ Headington JT. Purpura fulminans: a cutaneous manifestation of severe protein C deficiency Arch Dermatol 124 1988 1387 1391
131. Adcock DM Brozna J Marlar RA. Proposed classification and pathologic mechanisms of purpura fulminans and skin necrosis Semin Thromb Haemost 16 1990 333 340
132. Adcock DM Hicks MJ. Dermatopathology of skin necrosis associated with purpura fulminans Semin Thromb Haemost 16 1990 283 292
133. Estelles A Garcia-Plaza I Dasi A Severe inherited protein C deficiency in a newborn infant Thromb Haemost 52 1984 53 56
134. Marlar RA Montgomery RR Broekmans AW. Report on the diagnosis and treatment of homozygous protein C deficiency: report of the working party on homozygous protein C deficiency of the ISTH—subcommittee on protein C and protein S Thromb Haemost 61 1989 529 531
135. Dreyfus M Magny JF Bridey F Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate N Engl J Med 325 1991 1565 1568
136. Mahasandana C Suvatte V Chuansumvita A Homozygous protein S deficiency in an infant with purpura fulminans J Pediatr 117 1990 750 753
137. Marlar RA Montgomery RR Broekmans AW Diagnosis and treatment of homozygous protein C deficiency J Pediatr 114 1989 528 534
138. Andrew M Halton J Massicotte MP. Treatment of homozygous Protein C deficiency in two children with low molecular weight heparin (LMWH) therapy [abstract] Thromb Haemost 73 6 1995 939
139. Hong CY Yun YS Choi JY Takayasu arteritis in Korean children: clinical report of 70 cases Heart Vessels 7 1992 91 96
140. Zheng D Fan D Liu L. Takayasu arteritis in China: a report of 530 cases Heart Vessels 7 1992 32 36
141. Wiggelinkhuizen J Cremin BJ Cywes S. Spontaneous recanalization of renal artery stenosis in childhood Takayasu arteritis: a case report S Afr Med J 57 1980 96 98
142. Hall TR McDiarmid SV Grant EG False-negative duplex Doppler studies in children with hepatic artery thrombosis after liver transplantation AJR 154 1990 573 575
143. Flint EW Sumkin JH Zajko AB Duplex sonography of hepatic artery thrombosis after liver transplantation AJR 151 1988 481 483
144. Lerut JP Gordon RD Tzakis AG The hepatic artery in orthotopic liver transplantation Helvet Chir Acta 55 1988 367 378
145. LeBlanc JG Culham JAG Chan KW Treatment of grafts and major vessel thrombosis with low-dose streptokinase in children Ann Thorac Surg 41 1986 630 635
146. Samara EN Voss BL Pederson JA. Renal artery thrombosis associated with elevated cyclosporine levels: a case report and review of the literature Transplant Proc 20 1988 119 123
147. Koren G Rose V Lavi S Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease JAMA 254 1985 767 769
148. Daniels SR Specker P Capannari TE Correlates of coronary artery aneurysm formation in patients with Kawasaki disease AJDC 141 1987 205 207
149. Freed MD Keane JF Rosenthal A. The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children Circulation 50 1974 565 569
150. Freed MD Rosenthal A Fyler D. Attempts to reduce arterial thrombosis after cardiac catheterization in children: use of percutaneous technique and aspirin Am Heart J 87 1974 283 286
151. Rajani K Goetzman BW Wennberg RP Effect of heparinization of fluids infused through an umbilical artery catheter on catheter patency and frequency of complications Pediatrics 63 1979 552 556
152. Jackson JC Truog WE Watchko JF Efficacy of thromboresistant umbilical artery catheters in reducing aortic thrombosis and related complications J Pediatr 110 1987 102 105
153. David RJ Merten DF Anderson JC Prevention of umbilical artery catheter clots with heparinized infusates Dev Pharmacol Ther 2 1981 117 126
154. Bosque E Weaver L. Continuous versus intermittent heparin infusion of umbilical artery catheters in the newborn infant J Pediatr 108 1986 141 143
155. Horgan MJ Bartoletti A Polonsky S Effect of heparin infusates in umbilical arterial catheters on frequency of thrombotic complications J Pediatr 111 1987 774 778
156. Ankola PA Atakent YS. Effect of adding heparin in very low concentration to the infusate to prolong the patency of umbilical artery catheters Am J Perinatol 10 1993 229 232
157. Lesko SM Mitchell AA Eopstein MF Heparin use a risk factor for intraventricular hemorrhage in low birth weight infants N Engl J Med 314 1986 1156 1160
158. Sade RM Ballenger JF Hohn AR Cardiac valve replacement in children: comparison of tissue with mechanical prostheses J Thorac Cardiovasc Surg 78 1979 123 127
159. Brown JW Dunn JM Spooner E Late spontaneous disruption of a porcine xenograft mitral valve: clinical, hemodynamic, echocardiographic, and pathologic findings J Thorac Cardiovasc Surg 75 1978 606 611
160. Geha AS Laks H Stansel HC Jr Late failure of porcine valve heterografts in children J Thorac Cardiovasc Surg 78 1979 351 364
161. Silver MM Pollock J Silver MD Calcification in porcine xenograft valves in children Am J Cardiol 45 1980 685 689
162. Dunn JM. Porcine valve durability in children Ann Thorac Surg 32 1981 357 368
163. Williams WG Pollack JC Geiss DM Experience with aortic and mitral valve replacement in children J Thorac Cardiovasc Surg 81 1981 326 333
164. Miller DC Stinson EB Oyer PE The durability of porcine xenograft valves and conduits in children Circulation 66 suppl 1, pt 2 1982 I172 85
165. Odell JA. Calcification of porcine bioprostheses in children Cohn LH Gallucci V Cardiac bioprostheses: proceedings of the second international symposium 1982 Yorke Medical Books New York 231
166. Williams DB Danielson GK McGoon DC Porcine heterograft valve replacement in children J Thorac Cardiovasc Surg 84 1982 446 450
167. Milano A Vouhe PR Baillot-Vemant F Late results after left-sided cardiac valve replacement in children J Thorac Cardiovasc Surg 92 1986 218 225
168. Massicotte P Marzinotto V Adams M Enhanced thrombin regulation during warfarin therapy in children compared to adults Ped Res 37 4 1995 162 A
169. Taussig HB. Long-time observations on the Blalock-Taussig operation: IX. Single ventricle (with apex to the left) Johns Hopkins Med J 139 1976 69 76
170. Truccone NJ Bowman FO Jr Malm JR Systemicpulmonary arterial shunts in the first year of life Circulation 49 1974 508 511
171. Tamisier D Vouhe PR Vernant F Modified Blalock-Taussig shunts: results in infants less than 3 months of age Ann Thorac Surg 49 1990 797 801
172. Bjork VO Olin CL Bjarke BB Right atrial-right ventricular anastomosis for correction of tricuspid atresia J Thorac Cardiovasc Surg 77 1979 452 458
173. Breman FO Jr Malm JR Hayes CJ Physiological approach to surgery for tricuspid atresia Circulation 58 suppl l 1978 I 83
174. Fontan F Baudet E. Surgical repair of tricuspid atresia Thorax 26 1971 240 248
175. Jonas RA Castancda AR. Modified Fontan procedure: atrial baffle and systemic venous to pulmonary artery anastomotic techniques J Card Surg 3 1988 91 96
176. Du Plessis AJ Chang AC Wessel DL Cerebrovascular accidents following the Fontan operation Pediatr Neurol 12 1995 230 236
177. Zahn EM Lima VC Benson LN Use of endovascular stents to increase pulmonary blood flow in pulmonary atresia with ventricular septal defect Am J Cardiol 70 1992 411 412
178. Peeters S Vandenplas Y Jochmans K Myocardial infarction in a neonate with hereditary antithrombin III deficiency Acta Paediatr 82 1993 610 613
179. Andrew M MacIntyre B Williams WG Heparin therapy during cardiopulmonary bypass requires ongoing quality control Thromb Haemost 70 1993 937 941
180. Babacan MK Tasdemir O Yakut C Heparin need of the patients with cyanotic congenital heart disease during cardiopulmonary bypass J Cardiovasc Surg 30 1989 348 350
181. Akl BF Vargas GM Neal J Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass J Thorac Cardiovasc Surg 79 1980 97 102
182. Boonstra PW Gu YJ Akkerman C Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass J Thorac Cardiovasc Surg 107 1994 289 292
183. Whittlesey GC Drucker DEM Salley SO ECMO without heparin: laboratory and clinical experience J Pediatr Surg 26 1991 320 325
184. Green TP Isham-Schopf B Irmiter RJ Inactivation of heparin during extracorporeal circulation in infants Clin Pharmacol Ther 48 1990 148 154
185. Wilson JM Bower LK Fackler JC Aminocaproic acid decreases the incidence of intracranial hemorrhage and other hemorrhagic complications of ECMO J Pediatr Surg 28 1993 536 541
186. Zobel G Trop M Muntean W Anticoagulation for continuous arteriovenous hemofiltration in children Blood Purif 6 1988 90 95
187. Zobel G Beitzke A Stein JI Continuous arteriovenous haemofiltration in children with postoperative cardiac failure Br Heart J 58 1987 473 476
188. Leone MR Jenkins RD Golper TA Early experience with continuous arteriovenous hemofiltration in critically ill pediatric patients Crit Care Med 14 1986 1058
189. Suarez SM Palier AS. Atrophie blanche with onset in childhood J Pediatr 123 1993 753 755
190. Arenson EB August CS. Preliminary report: treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole J Pediatr 86 1975 957 961
191. Thorenson CA Rossi EC Green D The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function Am J Med 66 1979 711 716
192. O'Regan S Chesney RW Mongeau JG Aspirin and dipyridamole therapy in the hemolytic-uremic syndrome J Pediatr 97 1980 473 476
193. Van Damme-Lombaerts R Proesmans W Van Damme B Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: a prospective, randomized study J Pediatr 113 1988 913 918
194. Harker LA Slichter SJ Scott CR Homocysteinemia: vascular injury and arterial thrombosis N Engl J Med 291 1974 537 543
195. Uhlemann ER TenPas JH Lucky AW Platelet survival and morphology in homocysteinuria due to cystathionone synthase deficiency N Engl J Med 295 1976 1283 1286
196. Shulman JD Agarwal B Mudd SH Pulmonary embolism in a homocystinuric patient during treatment with dipyridamole and acetylsalicylic acid [letter] N Engl J Med 299 1978 661
197. Schaffer MS Clarke DR Campbell DN The St. Jude medical cardiac valve and children: role of anticoagulant therapy J Am Coll Cardiol 9 1987 235 239
198. Human DG Joffe HS Fraser CB Mitral valve replacement in children J Thorac Cardiovasc Surg 83 1982 873 877
199. Antunes MJ Vanderdonck KM Sussman MJ. Mechanical valve replacement in children and teenagers Eur J Cardiothorac Surg 3 1989 222 228
200. Stein PD Grandison D Hua TA Therapeutic levels of oral anticoagulation with warfarin in patients with mechanical prosthetic heart valves: review of literature and recommendations based on international normalized ratio Postgrad Med J 70 suppl l 1994 S72 83
201. Turpie AGG Gent M Laupacis A Comparison of aspirin with placebo in patients treated with warfarin after heart valve replacement N Engl J Med 329 1993 524 529
202. Rajah SM Sreeharan N Joseph A Prospective trial of dipyridamole and warfarin in heart valve patients [abstract] Acta Ther (Brussels) 6 1980 54
203. Turpie AGG Gunstensen J Hirsh J Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement Lancet 1 1988 1242 1245
204. Newburger J Takahashi M Burns J The treatment of Kawasaki syndrome with intravenous gamma globulin N Engl J Med 315 1986 341 347
205. Corrazza MS Davis RF Merritt A Prolonged bleeding time in preterm infants receiving indomethacin for patent ductus arteriosus J Pediatr 105 1984 292 296